Enhancing Patient Access to Digital Therapeutics - Insights from Trinity, LLC
This presentation by Trinity, LLC delves into enabling patient access to digital therapeutics, offering a deep dive into the current scenario, expected growth, and collaborations in the digital therapeutics market. Featuring expert panelists and insightful discussions, it sheds light on the evolving
0 views • 31 slides
Understanding Spirits and Their Uses in Therapeutics and Flavoring
Spirits, also known as essences, are alcoholic or hydro-alcoholic solutions containing volatile substances. They can be classified based on therapeutic or flavoring purposes. These solutions are prepared by distillation or dissolving volatile substances in alcohol, with varying alcohol content. Spir
4 views • 17 slides
Single-Cell Transcriptomics of TAZ-Deficient Murine Corneal Endothelium
This study explores the single-cell transcriptomics of TAZ-deficient murine corneal endothelium in the context of Fuchs Endothelial Corneal Dystrophy (FECD), a polygenic disease affecting millions globally. The research utilizes a TAZ-deficient mouse model to mimic late-onset FECD, revealing reduced
2 views • 39 slides
Global Allergy Therapeutics Market
The Global Allergy Therapeutics Market Size is Anticipated to Exceed USD 42.5 Billion by 2033, Growing at a CAGR of 6.29% from 2023 to 2033.\n
0 views • 5 slides
Advances in ADNI Genetics Research and Studies Update
Explore the latest advancements in ADNI genetics research, including updates on sample collections, longitudinal DNA and RNA studies, pathway analysis, genetic signal to therapeutics, use of genetic data, and publications on ADNI endophenotypes. The content also covers the most frequently reported g
0 views • 18 slides
AHCCCS Pharmacy and Therapeutics Committee Meeting Highlights
The AHCCCS Pharmacy and Therapeutics Committee meeting on October 16, 2019, covered various topics including conflict of interest training, Magellan class reviews, and discussions on oral antifungals. The meeting aimed at providing comprehensive quality healthcare in Arizona, focusing on drug review
0 views • 162 slides
Opportunities for Undergraduates in Health Research Lab
The Mohan Research Lab offers undergraduates the chance to conduct impactful research that can be published, focusing on biomarkers and targets for autoimmune diseases and cancers. Led by an international team of researchers, the lab provides a collaborative environment for students to engage in cut
4 views • 12 slides
Advances in Antimicrobial Drugs: Selective Toxicity and Classification
The development of antimicrobial drugs has significantly improved therapeutics by controlling infections and preventing complications. These drugs target invading microorganisms using selective toxicity, sparing host cells. Antimicrobial drugs are classified based on site, mechanism of action, and c
0 views • 30 slides
Research Support Services Process Maps for Ethics Review & Site Authorisation
The process maps outline the steps for ethics review and site authorisation in October 2016, including the review of low to high-risk projects, submission of research proposals, and approval processes by the Human Research Ethics Committee (HREC) and Therapeutics Committee.
0 views • 5 slides
Optimizing Glycoprofiling Analytical Method for Therapeutic Proteins
Glycoproteins play a significant role in biopharmaceuticals, necessitating detailed characterization due to their structural heterogeneity from glycosylation. This study focuses on developing a robust and cost-effective characterization method using a Definitive Screening Design to optimize an HPAE-
0 views • 13 slides
Proposed Updates for Health Science Program of Study in Texas
Recommended updates for the Health Science Program of Study by the Texas Education Agency's Career and Technology Education Advisory Committee include merging certain programs, adding new courses, and updating postsecondary opportunities to align with industry needs. The focus is on providing studen
0 views • 6 slides
Global mRNA Therapeutics Market
The Global mRNA Therapeutics Market Size is expected to reach USD 38.15 Billion by 2030, at a CAGR of 2.2% during the forecast period 2022 to 2030.\n\n
1 views • 5 slides
Maternal & Infant Health R&D Grant Program Round 2 Information
The Maternal & Infant Health R&D Grant Program Round 2 aims to support innovation in technology, therapeutics, and solutions for maternal and infant health challenges in New Jersey. Target industries include Life Sciences, Technology, and Food & Beverage. The program offers competitive grants of up
0 views • 15 slides
AHCCCS Pharmacy and Therapeutics Committee Recommendations May 23, 2023
The AHCCCS Pharmacy and Therapeutics Committee made recommendations on various drug classes, including Analgesics, Narcotics, Antibiotics, Inhaled, Anticoagulants, and Antimigraine Agents. The recommendations specify preferred products and changes in preferred status for certain medications. Brand p
0 views • 45 slides
Role of Cell Cycle in Nanoparticle Uptake and Dilution in Cell Population
The cell cycle plays a crucial role in the cellular uptake and dilution of nanoparticles within a cell population. This process involves different phases such as G1, S, G2, and M, each with specific functions related to cell growth, DNA synthesis, protein synthesis, and cell division. Understanding
0 views • 20 slides
LTC Reporting Requirements and COVID-19 Testing Resources in Illinois
LTC reporting requirements include point-of-care test results and vaccination reporting for CMS-certified skilled nursing facilities. The NHSN COVID-19 reporting pathway details resident impact, facility capacity, staff and personnel information, supplies and PPE availability, therapeutics administe
0 views • 5 slides
Understanding Volatile Oils in Pharmacognosy: Properties, Uses, and Applications
Volatile oils, also known as essential oils, are hydrophobic liquids extracted from plants containing volatile chemical compounds. These oils have diverse physical and chemical properties, making them valuable in various fields like aromatherapy, perfumery, and therapeutics. Learn about the differen
0 views • 12 slides
Mechanisms of Gene Regulation Through RNA Interference
Explore the intricate processes of gene expression control at the RNA level, focusing on ribo-regulation and RNA interference. Learn about mechanisms such as mRNA localization, degradation, splicing, and more, and discover the potentials of RNAi-based therapeutics through insightful learning objecti
0 views • 16 slides
Advances in Protein Therapeutics Characterization Using LC/MS
This presentation by Steve Madden, MassHunter Software Product Manager at Agilent Technologies, highlights the tools and techniques for protein characterization using LC/MS. The agenda covers topics like intact proteins, peptides, PTMs, glycan profiling, and more, emphasizing the importance of sampl
0 views • 30 slides
Overview of HEAL Initiative and EPPIC-Net Infrastructure
This presentation provides insights into the HEAL initiative and the purpose of the EPPIC-Net (Early Phase Pain Investigation Clinical Network). It highlights the goals of EPPIC-Net in accelerating early-phase clinical trials of non-addictive pain therapeutics to reduce opioid reliance. The structur
0 views • 20 slides
BARDA Just Breathe ARDS Therapeutics Pitch Event Details
BARDA is hosting the Just Breathe ARDS Therapeutics Pitch Event to find host-directed therapeutic candidates for an upcoming ARDS clinical trial. The presentation covers submission guidelines, event basics, submission deadlines, evaluation criteria, and more. Drug sponsors are invited to participate
0 views • 23 slides
Nonparametric Tolerance Interval Approach to Immunogenicity Assay Cut Point Determination
This content discusses the importance of determining the cut point for immunogenicity assays to detect anti-drug antibodies (ADA) in large-molecule therapeutics. It highlights the need for well-developed and validated assays to ensure drug efficacy and safety. The approach involves multiple-tiered v
0 views • 26 slides
Challenges in Supporting Neonatal Therapeutics: A Proposal Overview
Proposal presentation at HESI Annual Meeting discusses challenges in neonatal therapeutics, including off-label drug use in NICU, low clinical relevance in studies, and barriers to conducting neonatal trials. Mandates require inclusion of neonates in pediatric studies, but priorities and study desig
0 views • 22 slides
Advancements in Alzheimer Disease Therapeutics Program
The MGB Alzheimer Therapeutics Program is a collaborative effort leading to groundbreaking disease-modifying therapies for Alzheimer's disease. The development of Lecanemab (Leqembi), a monoclonal antibody targeting amyloid plaques, offers a new option to slow disease progression. The program's focu
0 views • 21 slides
Overview of Hospital Pharmacy Practice and Organization Structure
Hospital pharmacy practice encompasses various functions, including medication dispensing, inventory management, and specialized services like IV admixtures. The organizational structure involves committees, such as Pharmacy and Therapeutics, and key roles like the director of pharmacy. Automation p
0 views • 40 slides